Pazopanib in Treating Patients With Malignant Pleural Mesothelioma - Related Studies

Pazopanib in Treating Patients With Malignant Pleural Mesothelioma

This study has been suspended.

Study NCT00459862. Last updated on October 22, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Malignant Mesothelioma

2	Additional conditions recognized in this trial
		Mesothelioma

3	More general conditions related to this trial
		Adenoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Glandular and Epithelial
		Neoplasms, Mesothelial

4	Interventions listed in this trial
		pazopanib hydrochloride
		laboratory biomarker analysis

5	Sponsors listed in this trial
		North Central Cancer Treatment Group
		National Cancer Institute (NCI)